新型高敏心肌肌钙蛋白I免疫分析的分析性能评估
该研究评估了基于DxI平台的新型化学发光免疫分析法Access hs-TnI检测心肌肌钙蛋白I(cTnI)的分析性能,并与Access AccuTnI+3及ARCHITECT平台的高敏cTnI方法进行比较。结果显示Access hs-cTnI的检出限和定量限等分析性能显著优于Access AccuTnI+3,与ARCHITECT hs-cTnI方法相似,且肝素血浆与血清样本间cTnI值无差异,而EDTA血浆与肝素血浆间存在显著差异。
要点
- Access hs-cTnI的LoB、LoD、20%CV和10%CV的LoQ分别为0.6、1.3、2.1和5.3 ng/L。
- Access hs-cTnI分析性能显著优于Access AccuTnI+3,与ARCHITECT hs-cTnI方法相似。
- 肝素血浆与血清cTnI值无差异,EDTA血浆与肝素血浆间有显著差异。
核心结论
- Access hs-cTnI的分析灵敏度参数较Access AccuTnI+3显著改善,与ARCHITECT平台的高敏方法相似。
研究设计与样本
- 依据国际标准化方案评估空白限、检出限及10%和20% CV的定量限。
- 使用健康受试者和心脏病患者的肝素血浆样本及外部质量评估计划分发的质控样本。
主要发现
- Access hs-cTnI的LoB、LoD、20%CV和10%CV的LoQ分别为0.6、1.3、2.1和5.3 ng/L。
- Access hs-cTnI与Access AccuTnI+3和ARCHITECT hs-cTnI方法呈密切线性回归,但方法间存在系统差异。
- 肝素血浆与血清样本的cTnI值无差异,而EDTA血浆与肝素血浆样本的cTnI值存在显著差异。
关键数值与推荐
- Access hs-cTnI的LoB为0.6 ng/L,LoD为1.3 ng/L,20%CV的LoQ为2.1 ng/L,10%CV的LoQ为5.3 ng/L。
临床怎么用
- Access hs-cTnI可用于肝素血浆或血清样本的cTnI检测,但需注意EDTA血浆与肝素血浆间存在显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The study aim was to evaluate and compare the analytical performance of the new chemiluminescent immunoassay for cardiac troponin I (cTnI), called Access hs-TnI using DxI platform, with those of Access AccuTnI+3 method, and high-sensitivity (hs) cTnI method for ARCHITECT platform. METHODS: The limits of blank (LoB), detection (LoD) and quantitation (LoQ) at 10% and 20% CV were evaluated according to international standardized protocols. For the evaluation of analytical performance and comparison of cTnI results, both heparinized plasma samples, collected from healthy subjects and patients with cardiac diseases, and quality control samples distributed in external quality assessment programs were used. RESULTS: LoB, LoD and LoQ at 20% and 10% CV values of the Access hs-cTnI method were 0.6, 1.3, 2.1 and 5.3 ng/L, respectively. Access hs-cTnI method showed analytical performance significantly better than that of Access AccuTnI+3 method and similar results to those of hs ARCHITECT cTnI method. Moreover, the cTnI concentrations measured with Access hs-cTnI method showed close linear regressions with both Access AccuTnI+3 and ARCHITECT hs-cTnI methods, although there were systematic differences between these methods. There was no difference between cTnI values measured by Access hs-cTnI in heparinized plasma and serum samples, whereas there was a significant difference between cTnI values, respectively measured in EDTA and heparin plasma samples. CONCLUSIONS: Access hs-cTnI has analytical sensitivity parameters significantly improved compared to Access AccuTnI+3 method and is similar to those of the high-sensitivity method using ARCHITECT platform.
引用
- Masotti S, Prontera C, Musetti V, et al. Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin I. Clin Chem Lab Med. 2018. PMID: 28941350. doi:10.1515/cclm-2017-0387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。